Breaking News Instant updates and real-time market news.

BIIB

Biogen

$318.11

-0.21 (-0.07%)

09:10
11/23/16
11/23
09:10
11/23/16
09:10

Morgan Stanley expects big reversal today in Biogen shares

Morgan Stanley Matthew Harrison expects shares of Biogen (BIIB) to end the trading day flat or slightly higher. The stock is currently down $26.61, or 8%, to $291.50 in pre-market trading. With Biogen's aducanumab more potent than Eli Lilly's solanezumab, the Alzheimer's drug still has potential for success, Harrison tells investors in a research note. He points out that Lilly management noted that "the study results, including many secondary clinical endpoints, directionally favored solanezumab." Harrison sees hope in the amyloid hypothesis. The analyst has an Overweight rating on Biogen.

  • 29

    Nov

BIIB Biogen
$318.11

-0.21 (-0.07%)

11/09/16
RBCM
11/09/16
NO CHANGE
RBCM
Biotech stocks should be bought on post-election decline, says RBC Capital
RBC Capital recommends buying biotech stocks today on weakness. The firm notes that stocks usually rebound after they drop due to political events that don't affect their fundamentals, and it believes that the decline in biotech stocks today is in that category. The firm says that President-elect Trump probably won't focus on drug prices or Medicare reform. It adds that biotech companies should benefit from the fact that Congress will stay in GOP hands and the apparent failure of California's Proposition 61 initiative. The firm identifies Celgene (CELG), Biogen (BIIB), Vertex (VRTX), BioMarin (BMRN), and Prothena (PRTA) as its favorite names in the sector.
11/09/16
PIPR
11/09/16
NO CHANGE
PIPR
Piper sees improving environment for Biopharma M&A
The biotech sector is seeing a "massive relief rally" given the "surprise trifecta" of a Republican sweep, the voting down of Prop 61 in California and U.S. dollar weakness, Piper Jaffray analyst Joshua Schimmer tells investors in a research note. The door is now open to discuss potential repatriation of cash outside the U.S., which could be a green light on mergers and acquisitions, the analyst adds. He points out that Amgen (AMGN) and Gilead (GILD) hold the most overseas cash, with Celgene (CELG) and Biogen (BIIB) holding several billion as well. Schimmer believes the broader environment may be improving for M&A. He cautions, though, that the election of Trump does not remove the "major drug pricing overhang question."
11/23/16
SBSH
11/23/16
NO CHANGE
Target $305
SBSH
Neutral
Citi pegs potential Biogen downside to $287 on Lilly failure
In a research note dated yesterday, Citi analyst Robyn Karnauskas said shares of Biogen (BIIB) could fall to $286 should Eli Lilly's (LLY) Alzheimer's drug solanezumab fail in its Phase 3 study. After Lilly reported this morning that the trial failed, shares of Biogen are down 6%, or $18.60, to $299.51 in pre-market trading. Shares of Lilly are down 14%, or $10.77, to $65.22. Karnauskas estimated the downside range of Biogen on a failed solanezumab study at $287-$306. The analyst has a Neutral rating on Biogen.
11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Overweight
Piper's Schimmer proclaims amyloid hypothesis is not dead
Piper Jaffray analyst Joshua Schimmer says the failure of Eli Lilly's (LLY) solanezumab is not the final nail in the amyloid hypothesis coffin. Biogen (BIIB) and Eisai's aducanimab study is the most potent approach for amyloid lowering, Schimmer tells investors in a research note. He points out that he was skeptical whether solanezumab's effect was adequate. "Our view of Alzheimer's for amyloid is informed not so much by the extremely sloppy science in that disease, but by consistent cause/effect signals across other amyloidosis," Schimmer writes. He believes today's selloff in shares of Biogen "creates some breathing room." The analyst recommends looking to build a position in Biogen after the stock settles down. Schimmer reiterates an Overweight rating on the shares with a $335 price target. The stock is down 8%, or $24.41, to $293.70 in pre-market trading.

TODAY'S FREE FLY STORIES

13:07
09/22/17
09/22
13:07
09/22/17
13:07
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 9/22 Baker-Hughes…

RHHBY

Roche

$32.04

0.09 (0.28%)

13:07
09/22/17
09/22
13:07
09/22/17
13:07
Hot Stocks
Roche reports EU approval of Tecentriq in types of lung, bladder cancer »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

JUNO

Juno Therapeutics

$41.62

-3.59 (-7.94%)

13:05
09/22/17
09/22
13:05
09/22/17
13:05
Options
Juno Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 22

    Sep

BHGE

Baker Hughes

$36.40

-0.18 (-0.49%)

13:04
09/22/17
09/22
13:04
09/22/17
13:04
Hot Stocks
Baker Hughes reports U.S. rig count down 1 to 935 rigs »

Baker Hughes reports the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 20

    Oct

NVLN

Novelion Therapeutics

13:03
09/22/17
09/22
13:03
09/22/17
13:03
Hot Stocks
Novelion unit Aegerion settles SEC fraud charges for $4.1M »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDS

Dillard's

$55.07

-0.2189 (-0.40%)

, JWN

Nordstrom

$46.62

0.34 (0.73%)

13:02
09/22/17
09/22
13:02
09/22/17
13:02
Periodicals
Dillard's mentioned in 'vague rumors' about attempting to go-private, Kass says »

Douglas Kass of TheStreet…

DDS

Dillard's

$55.07

-0.2189 (-0.40%)

JWN

Nordstrom

$46.62

0.34 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MMM

3M

$211.18

0.74 (0.35%)

13:02
09/22/17
09/22
13:02
09/22/17
13:02
Hot Stocks
3M files patent, trademark infringement lawsuit against Thunder Finish »

3M and 3M Innovative…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FOSL

Fossil

$8.79

-0.21 (-2.33%)

12:55
09/22/17
09/22
12:55
09/22/17
12:55
Options
Fossil put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
09/22/17
09/22
12:55
09/22/17
12:55
Conference/Events
Federal Reserve Bank of Dallas President participates in a conference »

Dallas Federal Reserve…

CMCSA

Comcast

$37.47

0.01 (0.03%)

, FOX

21st Century Fox

$26.33

-0.05 (-0.19%)

12:53
09/22/17
09/22
12:53
09/22/17
12:53
Hot Stocks
Box Office Battle: 'Kingsman' sequel, 'LEGO: Ninjago' look to dethrone 'It' »

After two straight…

CMCSA

Comcast

$37.47

0.01 (0.03%)

FOX

21st Century Fox

$26.33

-0.05 (-0.19%)

VIAB

Viacom

$27.40

-0.32 (-1.15%)

SNE

Sony

$37.43

-0.035 (-0.09%)

DIS

Disney

$98.83

-0.06 (-0.06%)

CMCSK

Comcast

FOXA

21st Century Fox

$26.76

-0.11 (-0.41%)

VIA

Viacom

$38.20

-0.05 (-0.13%)

LGF.B

Lionsgate

$30.36

0.215 (0.71%)

TWX

Time Warner

$102.71

0.22 (0.21%)

LGF.A

Lionsgate

$31.57

0.32 (1.02%)

CBS

CBS

$58.85

0.06 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 29

    Sep

  • 22

    Oct

  • 26

    Oct

  • 02

    Nov

AAPL

Apple

$153.39

-2.68 (-1.72%)

, FSLR

First Solar

$48.76

-0.09 (-0.18%)

12:51
09/22/17
09/22
12:51
09/22/17
12:51
General news
On The Fly: Top stock stories at midday »

Stocks on Wall Street…

AAPL

Apple

$153.39

-2.68 (-1.72%)

FSLR

First Solar

$48.76

-0.09 (-0.18%)

FINL

Finish Line

$9.22

-0.21 (-2.23%)

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

W

Wayfair

$75.24

-6.51 (-7.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Oct

DDC

Dominion Diamond

$14.19

0.005 (0.04%)

12:49
09/22/17
09/22
12:49
09/22/17
12:49
Hot Stocks
Dominion Diamond receives court approval for plan with The Washington Companies »

Dominion Diamond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$249.20

-0.19 (-0.08%)

, VOO

Vanguard S&P 500 ETF

$228.89

-0.18 (-0.08%)

12:45
09/22/17
09/22
12:45
09/22/17
12:45
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week inflows…

SPY

SPDR S&P 500 ETF Trust

$249.20

-0.19 (-0.08%)

VOO

Vanguard S&P 500 ETF

$228.89

-0.18 (-0.08%)

XLF

Financial Select Sector

$25.43

-0.035 (-0.14%)

XLV

Health Care Select Sector SPDR

$81.25

-0.33 (-0.40%)

IWM

iShares Trust Russell 2000 Index Fund

$144.18

0.49 (0.34%)

GLD

SPDR Gold Trust

$123.09

0.41 (0.33%)

VWO

Vanguard FTSE Emerging Markets ETF

$44.17

-0.285 (-0.64%)

TLT

iShares 20+ Year Treasury Bond Fund

$125.84

-0.07 (-0.06%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$88.33

-0.01 (-0.01%)

IVV

iShares Core S&P 500

$252.18

-0.184 (-0.07%)

VO

Vanguard Mid-Cap Index Fund

$145.73

0.12 (0.08%)

VB

Vanguard Small-Cap Index Fund

$138.57

0.3 (0.22%)

VBK

Vanguard Small-Cap Growth Index Fund

$150.14

0.12 (0.08%)

MDY

SPDR S&P MidCap 400 ETF

$321.08

0.75 (0.23%)

SCHA

Schwab U.S. Small-Cap ETF

$65.69

0.19 (0.29%)

SVXY

ProShares Short VIX Short-Term Futures

$89.22

-0.5004 (-0.56%)

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$93.37

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
09/22/17
09/22
12:45
09/22/17
12:45
General news
Breaking General news story  »

Week of 9/22 Baker-Hughes…

ROK

Rockwell Automation

$177.39

0.06 (0.03%)

12:40
09/22/17
09/22
12:40
09/22/17
12:40
Options
Defensive option play opened in Rockwell »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$88.35

0.01 (0.01%)

12:30
09/22/17
09/22
12:30
09/22/17
12:30
Options
One week put buyer in the iShares High Yield Bond ETF »

One week put buyer in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$64.11

-0.89 (-1.37%)

12:25
09/22/17
09/22
12:25
09/22/17
12:25
Options
Activision Blizzard call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
09/22/17
09/22
12:25
09/22/17
12:25
Conference/Events
FDIC to hold a teleconference »

The FDIC examination…

$NSD

NASDAQ Market Internals

12:17
09/22/17
09/22
12:17
09/22/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
09/22/17
09/22
12:16
09/22/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$144.20

0.51 (0.35%)

12:10
09/22/17
09/22
12:10
09/22/17
12:10
Options
300K puts trade in iShares Small Cap Fund driven by spread trades »

300K puts trade in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$55.69

-1.6 (-2.79%)

, WRK

WestRock

$55.41

-2.2 (-3.82%)

12:09
09/22/17
09/22
12:09
09/22/17
12:09
Recommendations
International Paper, WestRock, KapStone analyst commentary  »

International Paper…

IP

International Paper

$55.69

-1.6 (-2.79%)

WRK

WestRock

$55.41

-2.2 (-3.82%)

KS

KapStone

$21.62

-0.96 (-4.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$366.48

-7.43 (-1.99%)

, CSIQ

Canadian Solar

$15.86

-0.16 (-1.00%)

12:05
09/22/17
09/22
12:05
09/22/17
12:05
Hot Stocks
ITC finds injury to U.S. solar product makers, moves to remedy phase »

The U.S. International…

TSLA

Tesla

$366.48

-7.43 (-1.99%)

CSIQ

Canadian Solar

$15.86

-0.16 (-1.00%)

FSLR

First Solar

$48.76

-0.09 (-0.18%)

JASO

JA Solar

$7.85

-0.335 (-4.09%)

SUNEQ

SunEdison

$0.02

0.0005 (2.44%)

SPWR

SunPower

$7.37

-0.49 (-6.23%)

TSL

Trina Solar

YGE

Yingli Green Energy

$2.43

0.02 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

NLNK

NewLink Genetics

$10.81

-0.5 (-4.42%)

12:05
09/22/17
09/22
12:05
09/22/17
12:05
Options
NewLink Genetics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

W

Wayfair

$76.19

-5.56 (-6.80%)

, OSTK

Overstock.com

$24.30

-0.1 (-0.41%)

12:02
09/22/17
09/22
12:02
09/22/17
12:02
Hot Stocks
Wayfair sinks after Citron highlights academic paper with $10.24 valuation »

Shares of Wayfair (W) are…Reference Link

W

Wayfair

$76.19

-5.56 (-6.80%)

OSTK

Overstock.com

$24.30

-0.1 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.